PeptiDream Inc
TSE:4587
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 168.5
2 968
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
PeptiDream Inc
PeptiDream Inc
Gross Profit
PeptiDream Inc
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PeptiDream Inc
TSE:4587
|
Gross Profit
¥35.5B
|
CAGR 3-Years
39%
|
CAGR 5-Years
46%
|
CAGR 10-Years
56%
|
|
|
GNI Group Ltd
TSE:2160
|
Gross Profit
¥19.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
29%
|
CAGR 10-Years
72%
|
|
|
Takara Bio Inc
TSE:4974
|
Gross Profit
¥24.8B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
3%
|
CAGR 10-Years
7%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Gross Profit
¥48.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
42%
|
CAGR 10-Years
49%
|
|
|
S
|
StemRIM Inc
TSE:4599
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Cuorips Inc
TSE:4894
|
Gross Profit
¥9.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
Glance View
PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. The company is headquartered in Kawasaki-Shi, Kanagawa-Ken and currently employs 141 full-time employees. The company went IPO on 2013-06-11. The firm operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The firm is involved in the business centered on drug development based on special peptides. The firm's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
See Also
What is PeptiDream Inc's Gross Profit?
Gross Profit
35.5B
JPY
Based on the financial report for Sep 30, 2024, PeptiDream Inc's Gross Profit amounts to 35.5B JPY.
What is PeptiDream Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
56%
Over the last year, the Gross Profit growth was 32%. The average annual Gross Profit growth rates for PeptiDream Inc have been 39% over the past three years , 46% over the past five years , and 56% over the past ten years .
You don't have any saved screeners yet
